Search

Your search keyword '"Al-Jardani A."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Al-Jardani A." Remove constraint Author: "Al-Jardani A." Region oman Remove constraint Region: oman
42 results on '"Al-Jardani A."'

Search Results

1. Childhood Hypertension: A Retrospective Analysis of Causes, Treatments, and Complications.

3. A Need for a Framework for Curriculum Evaluation in Oman

4. ELT and Consciousness-Raising

5. Hypervirulent Capsular Serotypes K1 and K2 Klebsiella pneumoniae Strains Demonstrate Resistance to Serum Bactericidal Activity and Galleria mellonella Lethality.

9. Time trend of respiratory viruses before and during the COVID‐19 pandemic in severe acute respiratory virus infection in the Sultanate of Oman between 2017 and 2022.

10. Genomic and geospatial epidemiology of Mycobacterium tuberculosis in Oman: first national insight using whole genome sequencing.

11. Prevalence of Hepatitis B Infection Among Pregnant Women in Oman.

12. Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity.

13. Dynamics of Mycobacterium tuberculosis Lineages in Oman, 2009 to 2018.

14. Validation of GeneXpert testing for SARS-CoV-2 RNA in eight hospital laboratories in Oman.

15. Community Foodborne of Salmonella Weltevreden Outbreak at Northern Governorate, Sultanate of Oman.

16. Epidemiological Characteristics of Pandemic Coronavirus Disease (COVID-19) in Oman.

17. Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.

18. Ongoing Challenges with Healthcare-Associated Candida auris Outbreaks in Oman.

19. Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions.

20. Serotype distribution and antibiotic resistance among invasive Streptococcus pneumoniae from Oman post 13-valent vaccine introduction.

21. Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman.

22. Epidemiology of Meningitis in Oman—Implications for Future Surveillance.

23. Estimating the burden of influenza‐associated hospitalization and deaths in Oman (2012‐2015).

24. The Spectrum of Bacille Calmette–Guérin Diseases in Children—A Decade of Data from Neonatal Vaccination Settings.

25. The first glycopeptide-intermediate Staphylococcus aureus in Oman.

26. The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: A multicenter seroprevalence study.

27. Molecular epidemiology of COVID-19 in Oman: A molecular and surveillance study for the early transmission of COVID-19 in the country.

28. Effects of COVID-19 on mortality: A 5-year population-based study in Oman.

29. COVID-19 epidemic monitoring after non-pharmaceutical interventions: The use of time-varying reproduction number in a country with a large migrant population.

30. Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries.

31. First report of human infection with avian influenza A(H9N2) virus in Oman: The need for a One Health approach.

32. Control of the 2018–2019 dengue fever outbreak in Oman: A country previously without local transmission.

33. Overview of preparedness and response for Middle East respiratory syndrome coronavirus (MERS-CoV) in Oman.

34. The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study.

35. Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman.

36. Challenges and Opportunities for Public Health Service in Oman From the COVID-19 Pandemic: Learning Lessons for a Better Future.

37. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.

38. The role of children and adolescents in the transmission of SARS-CoV-2 virus within family clusters: A large population study from Oman.

39. Screening migrants from tuberculosis high-endemic countries for latent tuberculosis in Oman: A cross sectional cohort analysis.

40. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.

41. Tuberculosis elimination: a dream or a reality? The case of Oman.

42. Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula.

Catalog

Books, media, physical & digital resources